XOMA Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-01-05 | BVF PARTNERS L P/IL | director | 1,788,168 | P-Purchase | A | 3,330 | 18.39 | 61,222.72 |
| 2023-01-06 | BVF PARTNERS L P/IL | director | 1,789,844 | P-Purchase | A | 1,676 | 21.98 | 36,841.33 |
| 2023-01-05 | BVF PARTNERS L P/IL | director | 1,617,064 | P-Purchase | A | 15,670 | 18.39 | 288,096.08 |
| 2023-01-06 | BVF PARTNERS L P/IL | director | 1,618,637 | P-Purchase | A | 1,573 | 21.98 | 34,577.21 |
| 2023-01-01 | Hughes Owen | None | 0 | None | None | 0.00 | ||
| 2023-01-03 | Sitko Bradley | director: Chief Investment Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
| 2023-01-03 | Sitko Bradley | director: Chief Investment Officer | 250,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2023-01-03 | Hughes Owen | director: Interim CEO | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2023-01-03 | Hughes Owen | director: Interim CEO | 75,000 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-01-03 | Sitko Bradley | None | 0 | None | None | 0.00 | ||
| 2022-11-08 | BURNS THOMAS M. | director: SVP, Finance & CFO | 11,000 | A-Award | A | 11,000 | 0.00 | 0.00 |
| 2022-07-15 | BURNS THOMAS M. | director: SVP, Finance & CFO | 6,555 | S-Sale | D | 2,000 | 31.66 | 63,321.00 |
| 2022-07-15 | BURNS THOMAS M. | director: SVP, Finance & CFO | 75,778 | M-Exempt | D | 2,000 | 0.00 | 0.00 |
| 2022-07-15 | Neal James R | director: CEO | 15,939 | S-Sale | D | 20,883 | 29.55 | 617,094.74 |
| 2022-07-15 | Neal James R | director: CEO | 218,056 | M-Exempt | D | 25,000 | 0.00 | 0.00 |
| 2022-05-18 | LAMPERT MARK N | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | PERRY MATTHEW D | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | LIMBER JOSEPH M | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | WYSZOMIERSKI JACK L | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | Hernday Natasha | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | VAN NESS W DENMAN | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | Kosacz Barbara | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-05-18 | Franklin Heather L | director: | 8,996 | A-Award | A | 8,996 | 0.00 | 0.00 |
| 2022-03-21 | Neal James R | director: CEO | 102,800 | M-Exempt | D | 1,111 | 0.00 | 0.00 |
| 2022-03-21 | Neal James R | director: CEO | 11,822 | S-Sale | D | 2,339 | 30.02 | 70,208.59 |
| 2022-03-21 | BURNS THOMAS M. | director: SVP, Finance & CFO | 6,555 | S-Sale | D | 2,339 | 30.02 | 70,208.59 |
| 2022-03-21 | BURNS THOMAS M. | director: SVP, Finance & CFO | 18,000 | M-Exempt | D | 12,000 | 0.00 | 0.00 |
| 2020-05-20 | WYSZOMIERSKI JACK L | director | 6,152 | A-Award | A | 6,152 | 21.27 | 130,853.04 |
| 2020-03-13 | BVF PARTNERS L P/IL | director | 1,247,676 | P-Purchase | A | 100,000 | 18.34 | 1,834,090.00 |
| 2020-03-16 | BVF PARTNERS L P/IL | director | 1,257,840 | P-Purchase | A | 10,164 | 15.73 | 159,916.31 |
| 2020-03-17 | BVF PARTNERS L P/IL | director | 1,265,953 | P-Purchase | A | 8,113 | 15.73 | 127,647.51 |
| 2018-11-15 | VAN NESS W DENMAN | director | 11,646 | M-Exempt | A | 4,667 | 4.03 | 18,808.01 |
| 2018-11-15 | VAN NESS W DENMAN | director | 14,672 | M-Exempt | A | 3,026 | 11.20 | 33,891.20 |
| 2018-11-15 | VAN NESS W DENMAN | director | 9,144 | S-Sale | D | 5,528 | 12.67 | 70,039.76 |
| 2018-11-15 | VAN NESS W DENMAN | director | 3,333 | M-Exempt | D | 4,667 | 4.03 | 18,808.01 |
| 2018-11-15 | VAN NESS W DENMAN | director | 0 | M-Exempt | D | 3,026 | 11.20 | 33,891.20 |
| 2017-02-10 | HUTT PETER BARTON | director | 8,000 | A-Award | A | 8,000 | 4.03 | 32,240.00 |
| 2017-03-02 | PERRY MATTHEW D | director | 11,799 | A-Award | A | 11,799 | 0.00 | 0.00 |
| 2017-03-02 | PERRY MATTHEW D | director | 15,222 | A-Award | A | 15,222 | 4.67 | 71,086.74 |
| 2016-05-28 | WYSZOMIERSKI JACK L | director | 81,068 | M-Exempt | A | 2,800 | 0.00 | 0.00 |
| 2016-05-28 | WYSZOMIERSKI JACK L | director | 0 | M-Exempt | D | 2,800 | 0.00 | 0.00 |
| 2016-05-28 | Walbert Timothy P | director | 81,068 | M-Exempt | A | 2,800 | 0.00 | 0.00 |
| 2016-05-28 | Walbert Timothy P | director | 0 | M-Exempt | D | 2,800 | 0.00 | 0.00 |
| 2016-03-22 | Neal James R | officer: VP Business Development | 411,339 | S-Sale | D | 19,813 | 0.78 | 15,547.26 |
| 2015-05-15 | Varian John | director, officer: CEO | 562,414 | M-Exempt | A | 10,000 | 1.24 | 12,400.00 |
| 2015-05-15 | Varian John | director, officer: CEO | 552,414 | S-Sale | D | 10,000 | 3.34 | 33,400.00 |
| 2015-05-15 | Varian John | director, officer: CEO | 90,392 | M-Exempt | D | 10,000 | 1.24 | 12,400.00 |
| 2015-03-23 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 119,467 | S-Sale | D | 32,742 | 3.94 | 128,879.06 |
| 2015-02-26 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 142,398 | A-Award | A | 64,900 | 0.00 | 0.00 |
| 2015-02-26 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 86,910 | A-Award | A | 86,910 | 3.83 | 332,865.30 |
| 2014-12-31 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 25,080 | I | 0 | 3.83 | 0.00 | |
| 2014-11-20 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 77,021 | M-Exempt | A | 5,000 | 3.04 | 15,200.00 |
| 2014-11-20 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 72,021 | S-Sale | D | 5,000 | 4.55 | 22,750.00 |
| 2014-11-20 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 72,040 | M-Exempt | D | 5,000 | 3.04 | 15,200.00 |
| 2014-10-28 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 77,021 | M-Exempt | A | 5,000 | 3.04 | 15,200.00 |
| 2014-10-28 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 72,021 | S-Sale | D | 5,000 | 4.57 | 22,829.00 |
| 2014-10-28 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 72,040 | M-Exempt | D | 5,000 | 3.04 | 15,200.00 |
| 2014-09-12 | BAKER BROS. ADVISORS LP | director | 2,843,653 | A-Award | A | 5,500 | 0.00 | 0.00 |
| 2014-09-12 | BAKER BROS. ADVISORS LP | director | 19,781,670 | A-Award | A | 5,500 | 0.00 | 0.00 |
| 2014-09-12 | BAKER BROS. ADVISORS LP | director | 524,349 | A-Award | A | 5,500 | 0.00 | 0.00 |
| 2014-09-12 | BAKER BROS. ADVISORS LP | director | 7,000 | A-Award | A | 7,000 | 4.73 | 33,110.00 |
| 2014-09-12 | BOWES WILLIAM K JR | director | 32,368 | A-Award | A | 5,500 | 0.00 | 0.00 |
| 2014-09-12 | BOWES WILLIAM K JR | director | 7,000 | A-Award | A | 7,000 | 4.73 | 33,110.00 |
| 2014-02-27 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 85,465 | A-Award | A | 43,448 | 0.00 | 0.00 |
| 2014-02-27 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 60,000 | A-Award | A | 60,000 | 8.91 | 534,600.00 |
| 2013-11-16 | Neal James R | officer: VP Business Development | 0 | D | 37,296 | 10.73 | 399,999.60 | |
| 2013-10-27 | Neal James R | officer: VP Business Development | 0 | D | 9,758 | 1.69 | 16,491.02 | |
| 2013-12-01 | Neal James R | officer: VP Business Development | 0 | D | 15,625 | 7.35 | 114,843.75 | |
| 2013-11-16 | Neal James R | officer: VP Business Development | 0 | D | 16,037 | 10.73 | 171,996.82 | |
| 2014-01-21 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 3,228 | S-Sale | D | 5,694 | 8.27 | 47,077.99 |
| 2014-01-21 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 8,922 | M-Exempt | A | 5,694 | 3.04 | 17,309.76 |
| 2014-01-21 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 104,040 | M-Exempt | D | 5,694 | 3.04 | 17,309.76 |
| 2013-06-11 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 27,448 | M-Exempt | A | 10,000 | 1.69 | 16,900.00 |
| 2013-06-11 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 17,448 | S-Sale | D | 10,000 | 4.00 | 40,000.00 |
| 2013-06-11 | SCANNON PATRICK J MD PHD | officer: Exec. VP & CSO | 13,274 | M-Exempt | D | 10,000 | 4.00 | 40,000.00 |
| 2013-05-28 | Walbert Timothy P | director | 7,299 | M-Exempt | A | 2,800 | 0.00 | 0.00 |
| 2013-05-28 | Walbert Timothy P | director | 5,600 | M-Exempt | D | 2,800 | 0.00 | 0.00 |
| 2012-12-31 | RUBIN PAUL D | officer: Sr. VP Clinical Dev. & CMO | 4,422 | I | 0 | 2.53 | 0.00 | |
| 2012-11-13 | Varian John | officer: Director and CEO | 4,499 | M-Exempt | A | 4,499 | 0.00 | 0.00 |
| 2012-11-13 | Varian John | officer: Director and CEO | 100,666 | M-Exempt | A | 96,167 | 0.00 | 0.00 |
| 2012-11-14 | Varian John | officer: Director and CEO | 98,852 | S-Sale | D | 1,814 | 2.56 | 4,640.94 |
| 2012-11-14 | Varian John | officer: Director and CEO | 60,079 | S-Sale | D | 38,773 | 2.56 | 99,165.82 |
| 2012-11-13 | Varian John | officer: Director and CEO | 297,496 | M-Exempt | D | 4,499 | 0.00 | 0.00 |
| 2012-11-13 | Varian John | officer: Director and CEO | 201,329 | M-Exempt | D | 96,167 | 0.00 | 0.00 |
| 2012-10-29 | BAKER JULIAN | director | 1,922,230 | P-Purchase | A | 336,639 | 3.00 | 1,009,917.00 |
| 2012-10-29 | BAKER JULIAN | director | 17,888,512 | P-Purchase | A | 4,282,419 | 3.00 | 12,847,257.00 |
| 2012-10-29 | BAKER JULIAN | director | 463,839 | P-Purchase | A | 103,608 | 3.00 | 310,824.00 |
| 2012-07-19 | Varian John | officer: Director and CEO | 391,805 | A-Award | A | 391,805 | 3.53 | 1,383,071.65 |
| 2012-07-19 | Varian John | officer: Director and CEO | 283,721 | A-Award | A | 283,721 | 0.00 | 0.00 |
| 2012-07-19 | SCANNON PATRICK J MD PHD | officer: Executive Vice President | 67,381 | A-Award | A | 67,381 | 3.53 | 237,854.93 |
| 2012-07-19 | SCANNON PATRICK J MD PHD | officer: Executive Vice President | 48,793 | A-Award | A | 48,793 | 0.00 | 0.00 |
| 2012-05-24 | VAN NESS W DENMAN | director | 13,050 | A-Award | A | 13,050 | 2.36 | 30,798.00 |
| 2012-05-24 | VAN NESS W DENMAN | director | 9,450 | A-Award | A | 9,450 | 0.00 | 0.00 |
| 2012-02-10 | RUBIN PAUL D | officer: VP Clinical Dev. & CMO | 54,615 | A-Award | A | 54,615 | 0.00 | 0.00 |
| 2011-12-30 | MARGOLIN CHRISTOPHER J | officer: VP, General Counsel & Sec'y | 15,853 | I | 0 | 1.16 | 0.00 | |
| 2011-10-27 | WYSZOMIERSKI JACK L | director | 17,544 | A-Award | A | 17,544 | 1.69 | 29,649.36 |
| 2011-10-27 | WYSZOMIERSKI JACK L | director | 13,495 | A-Award | A | 13,495 | 0.00 | 0.00 |
| 2011-10-27 | MARGOLIN CHRISTOPHER J | officer: VP, General Counsel & Sec'y | 37,642 | A-Award | A | 37,642 | 1.69 | 63,614.98 |
| 2011-10-27 | MARGOLIN CHRISTOPHER J | officer: VP, General Counsel & Sec'y | 51,248 | A-Award | A | 51,248 | 1.69 | 86,609.12 |
| 2011-10-27 | MARGOLIN CHRISTOPHER J | officer: VP, General Counsel & Sec'y | 68,377 | A-Award | A | 68,377 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.